Caplacizumab and treatment of iTTP without plasma exchange

Speakers: Paul Brinkkötter

Paul Brinkkötter is professor of medicine and nephrology at the University of Cologne, Germany with a deep interest in glomerular diseases and TMAs including iTTP and aHUS. He participates in the center for rare diseases at UoC and is involved in the primary care of patients with TMA, both within the hospital and in an ambulatory setting.